Antony Prabhu

1.1k total citations
19 papers, 813 citations indexed

About

Antony Prabhu is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Antony Prabhu has authored 19 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Genetics and 8 papers in Cancer Research. Recurrent topics in Antony Prabhu's work include Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (8 papers) and Tryptophan and brain disorders (6 papers). Antony Prabhu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (8 papers), Glioma Diagnosis and Treatment (8 papers) and Tryptophan and brain disorders (6 papers). Antony Prabhu collaborates with scholars based in United States, Italy and Ethiopia. Antony Prabhu's co-authors include Prakash Chinnaiyan, Bhaswati Sarcar, Soumen Kahali, Shiva Kant, Pravin Kesarwani, Elizabeth Kensicki, Katie L. Buelow, Stewart F. Graham, Peter Forsyth and Ichiro Nakano and has published in prestigious journals such as Nature Communications, PLoS ONE and Cancer Research.

In The Last Decade

Antony Prabhu

18 papers receiving 801 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Antony Prabhu United States 14 477 344 249 131 126 19 813
Xueran Chen China 19 729 1.5× 320 0.9× 102 0.4× 136 1.0× 162 1.3× 45 1.1k
Efstathios Boviatsis Greece 17 331 0.7× 201 0.6× 216 0.9× 150 1.1× 159 1.3× 31 786
Idoia García Spain 19 745 1.6× 348 1.0× 142 0.6× 66 0.5× 175 1.4× 28 1.0k
Yunhong Zha China 19 764 1.6× 348 1.0× 93 0.4× 58 0.4× 153 1.2× 35 1.1k
Ping Duan China 17 599 1.3× 402 1.2× 41 0.2× 121 0.9× 78 0.6× 48 997
Dyah Laksmi Dewi Japan 11 801 1.7× 296 0.9× 41 0.2× 101 0.8× 146 1.2× 11 1.0k
Xin Liang United States 9 317 0.7× 143 0.4× 93 0.4× 179 1.4× 155 1.2× 15 618
Trang Nguyen United States 19 786 1.6× 284 0.8× 159 0.6× 84 0.6× 162 1.3× 42 1.2k
Galina Gritsina United States 13 273 0.6× 147 0.4× 119 0.5× 276 2.1× 297 2.4× 17 831
Amit D. Gujar United States 12 624 1.3× 455 1.3× 93 0.4× 44 0.3× 182 1.4× 20 971

Countries citing papers authored by Antony Prabhu

Since Specialization
Citations

This map shows the geographic impact of Antony Prabhu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Antony Prabhu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Antony Prabhu more than expected).

Fields of papers citing papers by Antony Prabhu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Antony Prabhu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Antony Prabhu. The network helps show where Antony Prabhu may publish in the future.

Co-authorship network of co-authors of Antony Prabhu

This figure shows the co-authorship network connecting the top 25 collaborators of Antony Prabhu. A scholar is included among the top collaborators of Antony Prabhu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Antony Prabhu. Antony Prabhu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Kesarwani, Pravin, Shiva Kant, Yi Zhao, et al.. (2023). Quinolinate promotes macrophage-induced immune tolerance in glioblastoma through the NMDAR/PPARγ signaling axis. Nature Communications. 14(1). 1459–1459. 38 indexed citations
3.
Prabhu, Antony, Kristen E.N. Scott, Paul A. Stewart, et al.. (2020). A22 Integrated Proteometabolomic Analysis Reveals Metabolic Vulnerabilities in Small-Cell Lung Cancer. Journal of Thoracic Oncology. 15(2). S19–S19. 1 indexed citations
4.
Kant, Shiva, Pravin Kesarwani, Antony Prabhu, et al.. (2020). Enhanced fatty acid oxidation provides glioblastoma cells metabolic plasticity to accommodate to its dynamic nutrient microenvironment. Cell Death and Disease. 11(4). 253–253. 95 indexed citations
5.
Kesarwani, Pravin, Antony Prabhu, Shiva Kant, & Prakash Chinnaiyan. (2019). Metabolic remodeling contributes towards an immune-suppressive phenotype in glioblastoma. Cancer Immunology Immunotherapy. 68(7). 1107–1120. 43 indexed citations
6.
Kesarwani, Pravin, Antony Prabhu, Shiva Kant, et al.. (2018). Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma. Clinical Cancer Research. 24(15). 3632–3643. 52 indexed citations
7.
Kesarwani, Pravin, Antony Prabhu, Stewart F. Graham, et al.. (2018). Tryptophan Metabolism Contributes to Radiation-Induced Immune Checkpoint Reactivation in Glioblastoma. International Journal of Radiation Oncology*Biology*Physics. 102(3). S27–S27. 1 indexed citations
8.
Prabhu, Antony, Shiva Kant, Pravin Kesarwani, et al.. (2018). Integrative cross-platform analyses identify enhanced heterotrophy as a metabolic hallmark in glioblastoma. Neuro-Oncology. 21(3). 337–347. 25 indexed citations
10.
Prabhu, Antony, Pravin Kesarwani, Shiva Kant, Stewart F. Graham, & Prakash Chinnaiyan. (2017). Histologically defined intratumoral sequencing uncovers evolutionary cues into conserved molecular events driving gliomagenesis. Neuro-Oncology. 19(12). 1599–1606. 21 indexed citations
11.
Kesarwani, Pravin, Shiva Kant, Antony Prabhu, & Prakash Chinnaiyan. (2017). The interplay between metabolic remodeling and immune regulation in glioblastoma. Neuro-Oncology. 19(10). 1308–1315. 47 indexed citations
12.
Kesarwani, Pravin, et al.. (2017). GDC-0919 Modulates Tryptophan Metabolism in Glioblastoma and Enhances Radiation Response. International Journal of Radiation Oncology*Biology*Physics. 99(2). E601–E601. 1 indexed citations
13.
Prabhu, Antony, Bhaswati Sarcar, C. Ryan Miller, et al.. (2015). Ras-mediated modulation of pyruvate dehydrogenase activity regulates mitochondrial reserve capacity and contributes to glioblastoma tumorigenesis. Neuro-Oncology. 17(9). 1220–1230. 31 indexed citations
14.
Prabhu, Antony, Bhaswati Sarcar, Soumen Kahali, et al.. (2013). Cysteine Catabolism: A Novel Metabolic Pathway Contributing to Glioblastoma Growth. Cancer Research. 74(3). 787–796. 106 indexed citations
15.
Chinnaiyan, Prakash, Elizabeth Kensicki, Gregory Bloom, et al.. (2012). The Metabolomic Signature of Malignant Glioma Reflects Accelerated Anabolic Metabolism. Cancer Research. 72(22). 5878–5888. 143 indexed citations
16.
Prabhu, Antony, Bhaswati Sarcar, Soumen Kahali, Shan Yuan, & Prakash Chinnaiyan. (2012). Targeting the Unfolded Protein Response in Glioblastoma Cells with the Fusion Protein EGF-SubA. PLoS ONE. 7(12). e52265–e52265. 23 indexed citations
17.
Kahali, Soumen, Bhaswati Sarcar, Antony Prabhu, Edward Seto, & Prakash Chinnaiyan. (2012). Class I histone deacetylases localize to the endoplasmic reticulum and modulate the unfolded protein response. The FASEB Journal. 26(6). 2437–2445. 34 indexed citations
18.
Sarcar, Bhaswati, Soumen Kahali, Antony Prabhu, et al.. (2011). Targeting Radiation-Induced G2 Checkpoint Activation with the Wee-1 Inhibitor MK-1775 in Glioblastoma Cell Lines. Molecular Cancer Therapeutics. 10(12). 2405–2414. 91 indexed citations
19.
Chinnaiyan, Prakash, Sajeel Chowdhary, Antony Prabhu, et al.. (2011). Phase I trial of vorinostat combined with bevacizumab and CPT-11 in recurrent glioblastoma. Neuro-Oncology. 14(1). 93–100. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026